Researcher Next
Create account
← Back to directory

Ronnie Shapira‐Frommer

Researcher Next ID · RN-011027

Researcher · Medicine

Sheba Medical Center

, Israel

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
290
Citation count
28,728
H-index
48
i10-index
100

Research interests

Medicine
Cytokine Signaling Pathways and Interactions
Cancer Immunotherapy and Biomarkers
Ovarian cancer diagnosis and treatment
PARP inhibition in cancer therapy
Myeloproliferative Neoplasms: Diagnosis and Treatment

Publications

  • Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

    The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30445-9

  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Science · 2020 · 10.1126/science.abb5920

  • Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)32440-6

  • Pembrolizumab versus Ipilimumab in Advanced Melanoma

    New England Journal of Medicine · 2015 · 10.1056/nejmoa1503093

  • Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1105535

Current projects

    No projects listed.